EUVIMEDEUVIMED entdecken
Crossref

A Two‐Stage Strategy to Reprogram Cyanine Photosensitizers as Controllable‐Pyroptosis Inducers for Anticancer Phototherapy

Mengfan Han, Yan Ma, Yingrui Su, Dailin Feng, Feifei Cui, Zhiwen Fan, Xiujie Zhao iD, Jun Ye iD, Rimo Xi, Meng Meng iD

Advanced Healthcare Materials · 08.11.2026

DOI: 10.1002/adhm.71952 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 08.11.2026. Verfasst von Mengfan Han und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and KLMDASR of Tianjin, Nankai University, Tianjin, P. R. China. Die Arbeit nennt 26 Literaturangaben. Gefördert von: National Natural Science Foundation of China, State Key Laboratory of Natural and Biomimetic Drugs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pyroptosis, a lytic and inflammatory form of programmed cell death, provides a promising strategy for antitumor immunotherapy. However, controllable modulation of pyroptosis using phototherapeutic agents remains challenging. In this study, we report a two‐stage molecular reprogramming method to rationally design cyanine photosensitizers with tunable pyroptosis‐inducing activity. We first reprogram IR808 into a novel photosensitizer T808, by integrating a tetraphenylethylene unit with IR808, which consequently enhances excited ‐ state features related to intersystem crossing (ISC) and reactive oxygen species (ROS) generation capability, accompanied by inducing pyroptosis under irradiation. In the second process, T808 is conjugated with poly(ethylene glycol) (PEG) chains of varying lengths (M.W. 550, 1000, and 2000 Da) to finely modulate the pyroptotic efficacy. The relationship of PEG chain length with pyroptosis‐inducing activity is in the order of PT550 > T808 > PT1000 >> PT2000. Cellular and in vivo studies show that T808, PT550, and PT1000 treatments suppress tumor growth and induce pyroptosis with occurrence of immunogenic cell death (ICD). Even under a lower intratumoral injection dose (25 µM), T808 and PT550 therapies exhibit remarkable antitumor efficacy with measurable pyroptosis features. This work provides a new insight into reprogramming cyanine photosensitizers into pyroptosis‐active molecules, and proposes possible structural association of PEGylated cyanines with the pyroptosis activity.

Schlagwörter

Stichwörter der Autor:innen

PEGylationcyaninespyroptosis inducerrational design

Autor:innen und Institutionen

  • State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and KLMDASR of Tianjin, Nankai University, Tianjin, P. R. China.
  • Tianjin Key Laboratory for Modern Drug Delivery and High Efficiency, School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, P. R. China.
  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P. R. China.
  • Beijing Key Laboratory of Key Technologies for Natural Drug Delivery and Novel Formulations, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P. R. China.
  • State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, P. R. China.

ORCID-Profile: Xiujie Zhao, Jun Ye, Meng Meng

Förderung

  • National Natural Science Foundation of China
  • State Key Laboratory of Natural and Biomimetic Drugs

Zitieren

APA

Han, M., Ma, Y., Su, Y., Feng, D., Cui, F., Fan, Z., Zhao, X., Ye, J., Xi, R., & Meng, M. (2026). A Two‐Stage Strategy to Reprogram Cyanine Photosensitizers as Controllable‐Pyroptosis Inducers for Anticancer Phototherapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71952

Vancouver

Han M, Ma Y, Su Y, Feng D, Cui F, Fan Z, et al. A Two‐Stage Strategy to Reprogram Cyanine Photosensitizers as Controllable‐Pyroptosis Inducers for Anticancer Phototherapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71952

BibTeX
@article{Han2026,
  author = {Han, Mengfan and Ma, Yan and Su, Yingrui and Feng, Dailin and Cui, Feifei and Fan, Zhiwen and Zhao, Xiujie and Ye, Jun and Xi, Rimo and Meng, Meng},
  title = {A Two‐Stage Strategy to Reprogram Cyanine Photosensitizers as Controllable‐Pyroptosis Inducers for Anticancer Phototherapy},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.71952}
}
Kostenlos starten →